Avalon GloboCare Corp.ALBTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P26
Within normal range
Average
94.16%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 100.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | -100.00% |
| Q2 2023 | -80.71% |
| Q1 2023 | -51.33% |
| Q4 2022 | 11.36% |
| Q3 2022 | -33.04% |
| Q2 2022 | 118.09% |
| Q1 2022 | -66.56% |
| Q4 2021 | 55.73% |
| Q3 2021 | -6.16% |
| Q2 2021 | 12.01% |
| Q1 2021 | 2.04% |
| Q4 2020 | -12.38% |
| Q3 2020 | 48.00% |
| Q2 2020 | -41.50% |
| Q1 2020 | -33.57% |
| Q4 2019 | 56.36% |
| Q3 2019 | -72.08% |
| Q2 2019 | 522.92% |
| Q1 2019 | 307.49% |
| Q4 2018 | 2603.32% |
| Q3 2018 | 426.24% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |